Outcomes of surgical repair of Retinoschisis-associated retinal detachment compared to Rhegmatogenous retinal detachment.


Journal

BMC ophthalmology
ISSN: 1471-2415
Titre abrégé: BMC Ophthalmol
Pays: England
ID NLM: 100967802

Informations de publication

Date de publication:
04 Jan 2022
Historique:
received: 19 05 2021
accepted: 23 12 2021
entrez: 5 1 2022
pubmed: 6 1 2022
medline: 7 1 2022
Statut: epublish

Résumé

The aim of this study is to compare outcomes of primary retinal detachment (RD) repair in retinoschisis-associated RD (RSRD) and rhegmatogenous RD (RRD). This is a retrospective observational cohort study. Charts of 2247 consecutive patients operated for RD repair at the Centre hospitalier universitaire de Québec - Université Laval between 2014 and 2018 were reviewed. Patients with RSRD and RRD were included to compare the visual and anatomical outcomes of both groups. There were 41 patients (1.8%) with RSRD and 1661 patients (74%) with RRD. RSRD patients had more primary repair failures (n = 9, 22%, vs. n = 166, 10%; p = 0.013). The primary anatomical success rates for pars plana vitrectomy with and without scleral buckle (PPV-SB vs. PPV) as primary repair method were similar in both RSRD patients (n = 11/14, 79% vs. n = 20/25, 80%; p = 0.92) and RRD patients (n = 751/827, 91% vs. n = 641/721, 89%; p = 0.21). At final follow-up, best corrected visual acuity (VA) in logarithm of the minimum angle of resolution (logMAR) was 0.30 [0.10, 0.88] and 0.18 [0.10, 0.40] (p = 0.03) in RSRD patients and RRD patients, respectively. Presence of retinoschisis was associated with worse final VA (β 0.082, p < 0.001). Other predictive variables included female sex, macula-off presentation, number of RD quadrants involved, longer symptoms duration, worse baseline VA, and primary repair failure. The greatest predictors were worse baseline VA, primary repair failure, and macula-off status at presentation. Presence of retinoschisis did not significantly increase risk of primary repair failure in multivariable analysis (OR 1.45, 95% CI: 0.50-4.17; p = 0.49). Symptoms duration was the greatest effect factor associated with for primary repair failure (OR 1.37, 95% CI: 1.12-1.69; p = 0.003). RSRD is associated with more primary repair failure in univariate analysis, but not in multivariate analysis after adjusting for symptoms duration. It is however associated with worse final VA even after adjusting for primary repair failure. Both PPV and PPV-SB are valid repair methods for RSRD. However, RSRD remains a challenge to treat.

Sections du résumé

BACKGROUND BACKGROUND
The aim of this study is to compare outcomes of primary retinal detachment (RD) repair in retinoschisis-associated RD (RSRD) and rhegmatogenous RD (RRD).
METHODS METHODS
This is a retrospective observational cohort study. Charts of 2247 consecutive patients operated for RD repair at the Centre hospitalier universitaire de Québec - Université Laval between 2014 and 2018 were reviewed. Patients with RSRD and RRD were included to compare the visual and anatomical outcomes of both groups.
RESULTS RESULTS
There were 41 patients (1.8%) with RSRD and 1661 patients (74%) with RRD. RSRD patients had more primary repair failures (n = 9, 22%, vs. n = 166, 10%; p = 0.013). The primary anatomical success rates for pars plana vitrectomy with and without scleral buckle (PPV-SB vs. PPV) as primary repair method were similar in both RSRD patients (n = 11/14, 79% vs. n = 20/25, 80%; p = 0.92) and RRD patients (n = 751/827, 91% vs. n = 641/721, 89%; p = 0.21). At final follow-up, best corrected visual acuity (VA) in logarithm of the minimum angle of resolution (logMAR) was 0.30 [0.10, 0.88] and 0.18 [0.10, 0.40] (p = 0.03) in RSRD patients and RRD patients, respectively. Presence of retinoschisis was associated with worse final VA (β 0.082, p < 0.001). Other predictive variables included female sex, macula-off presentation, number of RD quadrants involved, longer symptoms duration, worse baseline VA, and primary repair failure. The greatest predictors were worse baseline VA, primary repair failure, and macula-off status at presentation. Presence of retinoschisis did not significantly increase risk of primary repair failure in multivariable analysis (OR 1.45, 95% CI: 0.50-4.17; p = 0.49). Symptoms duration was the greatest effect factor associated with for primary repair failure (OR 1.37, 95% CI: 1.12-1.69; p = 0.003).
CONCLUSIONS CONCLUSIONS
RSRD is associated with more primary repair failure in univariate analysis, but not in multivariate analysis after adjusting for symptoms duration. It is however associated with worse final VA even after adjusting for primary repair failure. Both PPV and PPV-SB are valid repair methods for RSRD. However, RSRD remains a challenge to treat.

Identifiants

pubmed: 34983458
doi: 10.1186/s12886-021-02232-7
pii: 10.1186/s12886-021-02232-7
pmc: PMC8725377
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

10

Informations de copyright

© 2021. The Author(s).

Références

Acta Ophthalmol. 2009 May;87(3):281-4
pubmed: 18937819
Retina. 2001;21(6):602-12
pubmed: 11756883
Arch Ophthalmol. 1961 Nov;66:631-42
pubmed: 14498243
Ophthalmology. 1990 Apr;97(4):470-4
pubmed: 2326026
Semin Ophthalmol. 2014 May;29(3):136-41
pubmed: 23879223
Br J Ophthalmol. 2017 Aug;101(8):1022-1026
pubmed: 28057646
Can J Ophthalmol. 2010 Apr;45(2):161-5
pubmed: 20379303
Eye (Lond). 2013 Dec;27(12):1425-6
pubmed: 24136569
Arch Ophthalmol. 1968 Jan;79(1):36-44
pubmed: 5635087
Retina. 2006 Jan;26(1):37-43
pubmed: 16395137
Arch Ophthalmol. 2005 Sep;123(9):1237-41
pubmed: 16157805
Graefes Arch Clin Exp Ophthalmol. 2007 Sep;245(9):1295-301
pubmed: 17318570
Ophthalmology. 2011 Jul;118(7):1429-34
pubmed: 21561662
Eye (Lond). 2002 Jul;16(4):359-64
pubmed: 12101441
Br J Ophthalmol. 2004 May;88(5):722-3
pubmed: 15090436

Auteurs

Jérôme Garneau (J)

Faculty of Medicine, Université Laval, Quebec, Canada.

Mélanie Hébert (M)

Faculty of Medicine, Université Laval, Quebec, Canada.
Department of Ophthalmology, Centre Universitaire d'Ophtalmologie, CHU de Québec - Université Laval (Hôpital du Saint-Sacrement), 1050 chemin Ste Foy, G1S4L8, Québec, Canada.

Eunice You (E)

Faculty of Medicine, Université Laval, Quebec, Canada.
Department of Ophthalmology, Centre Universitaire d'Ophtalmologie, CHU de Québec - Université Laval (Hôpital du Saint-Sacrement), 1050 chemin Ste Foy, G1S4L8, Québec, Canada.

Alexandre Lachance (A)

Faculty of Medicine, Université Laval, Quebec, Canada.
Department of Ophthalmology, Centre Universitaire d'Ophtalmologie, CHU de Québec - Université Laval (Hôpital du Saint-Sacrement), 1050 chemin Ste Foy, G1S4L8, Québec, Canada.

Serge Bourgault (S)

Faculty of Medicine, Université Laval, Quebec, Canada.
Department of Ophthalmology, Centre Universitaire d'Ophtalmologie, CHU de Québec - Université Laval (Hôpital du Saint-Sacrement), 1050 chemin Ste Foy, G1S4L8, Québec, Canada.

Mathieu Caissie (M)

Faculty of Medicine, Université Laval, Quebec, Canada.
Department of Ophthalmology, Centre Universitaire d'Ophtalmologie, CHU de Québec - Université Laval (Hôpital du Saint-Sacrement), 1050 chemin Ste Foy, G1S4L8, Québec, Canada.

Éric Tourville (É)

Faculty of Medicine, Université Laval, Quebec, Canada.
Department of Ophthalmology, Centre Universitaire d'Ophtalmologie, CHU de Québec - Université Laval (Hôpital du Saint-Sacrement), 1050 chemin Ste Foy, G1S4L8, Québec, Canada.

Ali Dirani (A)

Faculty of Medicine, Université Laval, Quebec, Canada. drdirani@gmail.com.
Department of Ophthalmology, Centre Universitaire d'Ophtalmologie, CHU de Québec - Université Laval (Hôpital du Saint-Sacrement), 1050 chemin Ste Foy, G1S4L8, Québec, Canada. drdirani@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH